Holds one active US DMF for favipiravir, filing since 2020. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF for favipiravir, filing since 2020. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF for favipiravir, filing since 2020. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for favipiravir, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for favipiravir, filing since 2021. Its GMP is recognised in 1 market.
Holds one active US DMF for favipiravir, filing since 2021.
Registered with SFDA (Saudi Arabia) for favipiravir.
Registered with SFDA (Saudi Arabia) for favipiravir. Its GMP is recognised in 1 market.
This page filters the worldwide Favipiravir manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for favipiravir and what filings they hold.
Chat with Fred, your AI analyst